[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sanuwave Health Inc (SNWV)

Sanuwave Health Inc (SNWV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 135,250
  • Shares Outstanding, K 8,598
  • Annual Sales, $ 44,050 K
  • Annual Income, $ 11,810 K
  • EBIT $ 6 M
  • EBITDA $ 9 M
  • 60-Month Beta 1.37
  • Price/Sales 3.20
  • Price/Cash Flow 9.64
  • Price/Book 86.71

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.05
  • Number of Estimates 2
  • High Estimate $0.05
  • Low Estimate $-0.14
  • Prior Year $-0.66
  • Growth Rate Est. (year over year) +92.42%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.35 +1.86%
on 05/04/26
21.17 -26.12%
on 04/17/26
-1.26 (-7.46%)
since 04/02/26
3-Month
15.35 +1.86%
on 05/04/26
26.85 -41.75%
on 02/06/26
-10.13 (-39.31%)
since 02/04/26
52-Week
15.35 +1.86%
on 05/04/26
46.58 -66.43%
on 08/11/25
-15.26 (-49.39%)
since 05/02/25

Most Recent Stories

More News
Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year

Sanuwave is pleased to announce preliminary revenues of $9.6 million to $9.7 million for the first quarter ended March 31, 2026, in line with prior guidance for Q1. EDEN PRAIRIE, Minn., April 16,...

SNWV : 15.64 (-0.57%)
Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025

Q4 2025 revenues were  $13.4 million , up 29.7% from Q4 2024. This was an all-time quarterly record for the Company. Full year 2025 revenues were $44.1 million up 35.0% from full year...

SNWV : 15.64 (-0.57%)
Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results

EDEN PRAIRIE, Minn., March 20, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will...

SNWV : 15.64 (-0.57%)
Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue

Sanuwave is pleased to announce preliminary revenues of $13.3 million to $13.4 million for the fourth quarter ended December 31, 2025. This represents the highest quarterly revenues in Company history....

SNWV : 15.64 (-0.57%)
Sanuwave to Participate in the 44th Annual J.P. Morgan Healthcare Conference

EDEN PRAIRIE, Minn., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of FDA-approved next-generation wound care products,...

SNWV : 15.64 (-0.57%)
Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupply

Healogics Wound Care Supply adds UltraMIST to its Group Purchasing Organization Healogics iSupply and Sanuwave collaborate to provide UltraMIST as an option for GPO members EDEN PRAIRIE, Minn.,...

SNWV : 15.64 (-0.57%)
Sanuwave Announces Q3 FY2025 Financial Results

Q3 2025 revenues were  $11.5 million , up 22% from $9.4 million in Q3 2024. This represents the highest quarterly revenues in Company history. Q3 2025 gross margin was 77.9% , versus...

SNWV : 15.64 (-0.57%)
Sanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results

EDEN PRAIRIE, Minn., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will...

SNWV : 15.64 (-0.57%)
CMS Publishes Final Rule for Calendar Year 2026 Physician Fee Schedule for UltraMIST Procedure (CPT code 97610)

CMS adopts Final Rule for 2026 Physician Fee Schedule in line with proposed rule for CPT code 97610 2026 rates for physician offices, home visits, long-term care, and hospitals are in line with the...

SNWV : 15.64 (-0.57%)
Roth MKM Reaffirms Their Buy Rating on Sanuwave Health (SNWV)

In a report released yesterday, Kyle Bauser from Roth MKM reiterated a Buy rating on Sanuwave Health, with a price target of $53.00. The company’s shares closed yesterday at $40.82.Elevate Your Investing...

SNWV : 15.64 (-0.57%)

Business Summary

SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in...

See More

Key Turning Points

3rd Resistance Point 16.83
2nd Resistance Point 16.48
1st Resistance Point 16.06
Last Price 15.64
1st Support Level 15.29
2nd Support Level 14.94
3rd Support Level 14.52

See More

52-Week High 46.58
Fibonacci 61.8% 34.66
Fibonacci 50% 30.97
Fibonacci 38.2% 27.28
Last Price 15.64
52-Week Low 15.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.